Colleen Merritt Severyn is director of Merck Global Regulatory Affairs and Clinical Safety (GRACS). Colleen currently leads the Business Continuity Program and GRACS Innovation Council. She has 17 years of project, portfolio and change management leadership experience. Previously, Colleen served as chief of staff to head of GRACS, led regulatory submissions management for Merck’s KEYTRUDA(R) program, and led design and execution of multiple strategic initiatives. Colleen received a B.S. Chemical Engineering (University of Maryland) and a Ph.D. Chemical Engineering (Pennsylvania State University), and is a certified Six Sigma Black Belt, Change Management Agent, Project Management Professional, Associate Business Continuity Professional.